Among these, oral GLP-1 drug development trends have emerged as a key focus, as the field shifts from injectable therapies to innovative oral treatments
Cardiovasc Diabetol 19:85 Breder I, Cunha Breder J, Bonilha I, Munhoz DB, Medorima STK, Oliveira DC, do Carmo HR, Moreira C, Kontush A, Zimetti F, Zanotti I, Carvalho LSF, Nadruz W, Muscelli E, Quinaglia T, Sposito AC (2020) EXCEED-BHS3 Trial Investigator
Rashidi-Nezhad, A., Talebi, S., Saebnouri, H., Akrami, S
Semaglutide injections work best when dosed consistently each week, but life happensand a missed dose is a common concern for people managing their weight with GLP-1 therapy
Research on peptide capsules generally shows that tetrapeptides like epitalon fare poorly when taken orally without specialized delivery systems designed to protect against gastric breakdown